Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Blogs
Expert Insights
Latest News
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Excellence Forums
Mantle Cell Lymphoma Excellence Forum
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ACCC Annual Meeting & Cancer Center Business Summit
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
Genitourinary Cancer
Featured
Conference Coverage
Advanced Oral Therapy Adherence Among Patients With Prostate Cancer
Patients with prostate cancer who were non-adherent to advanced oral therapies experienced substantially higher HCRU than those who were adherent.
Videos
Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition…
Videos
Impact of Oral Anticancer Agent Adherence on Survival Outcomes in Metastatic RCC
Michaela Dinan, PhD, discusses results from a study which investigated real-world adherence and outcomes associated…
Videos
Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with…
Videos
Hospital Efficiency Impact on Quality of Prostate Cancer Care
Ravi Jayadevappa, PhD, MS, discusses the association between hospital efficiency and quality of care in African…
News
Health Care Spending for High-Resource Patients With Prostate Cancer
RT Added to ADT Cost-Effective vs ADT Alone for Metastatic Prostate Cancer
Comparative Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
Long-Term QOL in Prostate Cancer Treated With Ultra-Hypofractionation RT vs Conventionally Fractioned RT
Guideline Updates
AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer
Interviews
Novel Liquid Biopsy for Prostate Cancer Projected to Save Millions for US Health Care System
Videos
Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer
Podcast
Episode 52: Advances in Prostate Cancer With Neeraj Agarwal
Conference Coverage
Nivolumab Plus Ipilimumab Cost-Effective for Intermediate or Poor Risk RCC
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top